Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

[HTML][HTML] Anti–SARS-CoV-2 natural products as potentially therapeutic agents

CH Kim - Frontiers in pharmacology, 2021 - frontiersin.org
Severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), a β-coronavirus,
is the cause of the recently emerged pandemic and worldwide outbreak of respiratory …

[HTML][HTML] Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro …

RK Mohapatra, L Perekhoda, M Azam… - Journal of King Saud …, 2021 - Elsevier
In this study, we examined five previously synthesized compounds and checked their
binding affinity towards the SARS-CoV-2 main protease (M pro) by molecular docking study …

[HTML][HTML] An understanding of coronavirus and exploring the molecular dynamics simulations to find promising candidates against the Mpro of nCoV to combat the …

MB Singh, R Sharma, D Kumar, P Khanna… - Journal of infection and …, 2022 - Elsevier
The first infection case of new coronavirus was reported at the end of 2019 and after then,
the cases are reported in all nations across the world in a very short period. Further, the …

[HTML][HTML] Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - frontiersin.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

[HTML][HTML] Use of antioxidants for the neuro-therapeutic management of COVID-19

N Cardenas-Rodriguez, C Bandala, A Vanoye-Carlo… - Antioxidants, 2021 - mdpi.com
Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of …

[HTML][HTML] Nutraceuticals and herbs in reducing the risk and improving the treatment of COVID-19 by targeting SARS-CoV-2

P Tagde, S Tagde, P Tagde, T Bhattacharya… - Biomedicines, 2021 - mdpi.com
The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as
a deadly or devastating disease is known to affect thousands of people every day, many of …

[HTML][HTML] In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2

R Abdizadeh, F Hadizadeh, T Abdizadeh - Molecular Diversity, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by
SARS-CoV-2 that generated serious damages for both the human population and the global …

[HTML][HTML] Design and development of novel nutraceuticals: Current trends and methodologies

T Tsiaka, E Kritsi, K Tsiantas, P Christodoulou… - Nutraceuticals, 2022 - mdpi.com
Over the past few years, nutraceuticals have gained substantial attention due to the health-
promoting and disease-preventing functions behind their nutritional value. The global …

Andrographis paniculata (Burm. F.) Wall. Ex Nees, Andrographolide, and Andrographolide Analogues as SARS-CoV-2 Antivirals? A Rapid Review

XY Lim, JSW Chan, TYC Tan, BP Teh… - Natural Product …, 2021 - journals.sagepub.com
Drug repurposing is commonly employed in the search for potential therapeutic agents.
Andrographis paniculata, a medicinal plant commonly used for symptomatic relief of the …